These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18262818)
1. Identification of a novel mutation V2321M of the cardiac ryanodine receptor gene of sudden unexplained death and a phenotypic study of the gene mutations. Nishio H; Iwata M; Tamura A; Miyazaki T; Tsuboi K; Suzuki K Leg Med (Tokyo); 2008 Jul; 10(4):196-200. PubMed ID: 18262818 [TBL] [Abstract][Full Text] [Related]
2. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Tester DJ; Spoon DB; Valdivia HH; Makielski JC; Ackerman MJ Mayo Clin Proc; 2004 Nov; 79(11):1380-4. PubMed ID: 15544015 [TBL] [Abstract][Full Text] [Related]
3. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. Tester DJ; Ackerman MJ J Am Coll Cardiol; 2007 Jan; 49(2):240-6. PubMed ID: 17222736 [TBL] [Abstract][Full Text] [Related]
4. Postmortem molecular analysis for fatal arrhythmogenic disease in sudden unexplained death. Nishio H; Suzuki K Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S119-20. PubMed ID: 19261510 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. Creighton W; Virmani R; Kutys R; Burke A J Mol Diagn; 2006 Feb; 8(1):62-7. PubMed ID: 16436635 [TBL] [Abstract][Full Text] [Related]
6. Postmortem molecular screening for cardiac ryanodine receptor type 2 mutations in sudden unexplained death: R420W mutated case with characteristics of status thymico-lymphatics. Nishio H; Iwata M; Suzuki K Circ J; 2006 Nov; 70(11):1402-6. PubMed ID: 17062961 [TBL] [Abstract][Full Text] [Related]
7. Hypertrophy of lymphoid organs is a possible phenotypic characteristic of R420W mutation of the cardiac ryanodine receptor gene: a study using a knock-in mouse model. Nishio H; Okudaira N; Matsushita K; Yoshimoto T; Sato T; Suzuki K Leg Med (Tokyo); 2014 Nov; 16(6):326-32. PubMed ID: 25087098 [TBL] [Abstract][Full Text] [Related]
8. Postmortem genetic screening of SNPs in RyR2 gene in sudden unexplained nocturnal death syndrome in the southern Chinese Han population. Huang L; Liu C; Tang S; Su T; Cheng J Forensic Sci Int; 2014 Feb; 235():14-8. PubMed ID: 24447446 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of unexplained drowning: new insights from a molecular autopsy. Tester DJ; Kopplin LJ; Creighton W; Burke AP; Ackerman MJ Mayo Clin Proc; 2005 May; 80(5):596-600. PubMed ID: 15887426 [TBL] [Abstract][Full Text] [Related]
10. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Jiang D; Wang R; Xiao B; Kong H; Hunt DJ; Choi P; Zhang L; Chen SR Circ Res; 2005 Nov; 97(11):1173-81. PubMed ID: 16239587 [TBL] [Abstract][Full Text] [Related]
11. Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro. Marjamaa A; Laitinen-Forsblom P; Wronska A; Toivonen L; Kontula K; Swan H Int J Cardiol; 2011 Mar; 147(2):246-52. PubMed ID: 19781797 [TBL] [Abstract][Full Text] [Related]
12. Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases. Larsen MK; Berge KE; Leren TP; Nissen PH; Hansen J; Kristensen IB; Banner J; Jensen HK Int J Legal Med; 2013 Jan; 127(1):139-44. PubMed ID: 22222782 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805 [TBL] [Abstract][Full Text] [Related]
14. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262 [TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms. Laitinen PJ; Swan H; Kontula K Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276 [TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of familial CPVT after 30 years. Beery TA; Shah MJ; Benson DW Biol Res Nurs; 2009 Jul; 11(1):66-72. PubMed ID: 19398417 [TBL] [Abstract][Full Text] [Related]
17. Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death. Thomas NL; George CH; Lai FA Cardiovasc Res; 2004 Oct; 64(1):52-60. PubMed ID: 15364613 [TBL] [Abstract][Full Text] [Related]
18. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Tester DJ; Kopplin LJ; Will ML; Ackerman MJ Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589 [TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction. George CH; Jundi H; Walters N; Thomas NL; West RR; Lai FA Circ Res; 2006 Jan; 98(1):88-97. PubMed ID: 16339485 [TBL] [Abstract][Full Text] [Related]
20. The role of molecular autopsy in unexplained sudden cardiac death. Tester DJ; Ackerman MJ Curr Opin Cardiol; 2006 May; 21(3):166-72. PubMed ID: 16601452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]